The primary pathways involved in stimulating cell growth in breast cancer are the ER and HER2/EGFR signaling pathways (Krishnamurti and Silverman, 2014; Nagini, 2017; Yip and Papa, 2021). This evidence concerns the gene EGFR and breast carcinoma.